| Literature DB >> 33447405 |
Jeong Uk Lim1, Jongyeol Oh2, Hyung Woo Kim2, Woo Ho Ban3, Eun Su Park4, Jick Hwan Ha2, Ju Sang Kim2, Sang Haak Lee3.
Abstract
BACKGROUND: Frozen sections prepared during medical thoracoscopy (MT) have precise diagnostic ability in pleural pathology and may assist in decision-making before pleurodesis. The present study evaluated the diagnostic sensitivity of frozen sections from flex-rigid MT, and further evaluated clinical parameters for their association with a discrepancy between frozen sections and permanent paraffin sections.Entities:
Keywords: Frozen section; malignancy; pleura; thoracoscopy
Year: 2020 PMID: 33447405 PMCID: PMC7797841 DOI: 10.21037/jtd-20-1809
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895
Figure 1Pathological findings of patients who had discrepant results between fresh frozen sections and the final paraffin diagnosis. (A,B) Patient No. 2 who was finally diagnosed with metastatic lung adenocarcinoma: (A) fresh frozen section (hematoxylin and eosin staining; magnification, ×100); (B) final paraffin section (hematoxylin and eosin staining; magnification, ×100). (C,D,E,F) Patient No. 8 who was finally diagnosed with malignant mesothelioma: (C) fresh frozen section (hematoxylin and eosin staining; magnification, ×100); (D) final paraffin section (hematoxylin and eosin staining; magnification, ×40); (E) final paraffin section (hematoxylin and eosin staining; magnification, ×100); (F) final paraffin section (calretinin staining; magnification, ×100). Atypical cells (A, black arrow) are present, but are not diagnostic for malignancy. The glandular tumor cells (B, black arrow) invaded the fibrotic layer. The fresh frozen section shows mesothelial hyperplasia (C, black arrow) and glandular formation. Paraffin sections (D,E))) show more diagnostic findings: epithelioid mesothelial cell proliferation invading the surrounding fibrosis. Calretinin stain was positive (F).
Clinical characteristic of the study patients
| Characteristic | Data (n=172) |
|---|---|
| Age (mean ± SD) | 69.1±12.9 |
| Male sex | 108 (62.8) |
| Smoking status | |
| Current | 24 (14.0) |
| Former | 70 (40.7) |
| Never | 78 (45.3) |
| Previous malignancy | 32 (18.6) |
| Known previous tuberculosis | 16 (9.3) |
| Radiologic finding | |
| Effusion site | |
| Neither/Rt./Lt./Bilat. | 7 (4.1)/88 (51.5)/61 (35.7)/15 (8.8) |
| Effusion amount | |
| <25%/25–50%/>50% of hemithorax on CXR | 63 (36.8)/71 (41.5)/37 (21.6) |
| Suspected diagnosis before thoracoscopy | |
| Lung cancer (including previously confirmed cases) | 66 (38.4) |
| Mesothelioma | 6 (3.5) |
| Other malignancy | 29 (16.9) |
| Tuberculosis | 51 (29.7) |
| Undiagnosed cytology negative effusion | 21 (12.2) |
| Procedure duration (minutes) (mean ± SD) | 60.3±12.8 |
| Number of tissue samples acquired | 18.1±7.2 |
| Talc pleurodesis performed during thoracoscopy | 80 (46.5) |
| Final diagnosis with thoracoscopic biopsy | |
| Lung cancer | 79 (45.9) |
| Mesothelioma | 4 (2.3) |
| Other cancer* | 2 (1.2) |
| Tuberculosis | 32 (18.6) |
| Other benign | 53 (30.8) |
| Undiagnosed (needs further evaluation) | 2 (1.2) |
*, one peritoneal origin cancer and one clear renal cell cancer. Bilat, bilateral; CXR, chest X-ray; Lt, left; Rt, right; SD, standard deviation.
Comparison of clinical characteristics between frozen biopsy negative versus positive malignant cases
| Frozen/Permanent (+/+) (n=75) | Frozen/Permanent (–/+) (n=10) | P value | |
|---|---|---|---|
| Age | 70.1±10.6 | 72.7±12.2 | 0.867 |
| Male sex | 40 (53.3%) | 4 (40.0%) | 0.428 |
| Previous malignancy | 16 (21.3%) | 2 (20.0%) | 0.923 |
| Known previous tuberculosis | 8 (10.7%) | 0 (0.0%) | 0.278 |
| Radiologic finding | |||
| Effusion site (neither/Rt./Lt./bilateral) | 1 (1.3%)/34 (45.3%)/36 (48.0%)/4 (5.3%) | 0 (0.0%)/3 (33.3%)/6 (66.7%)/0 (0.0%) | 0.700 |
| Effusion amount | |||
| <25%/25–50%/>50% of hemithorax on CXR | 20 (26.6%)/32 (42.7%)/23 (30.7%) | 1 (11.1%)/5 (55.6%)/3 (33.3%) | 0.771 |
| Pulmonary mass or nodules | 57 (76.0%) | 6 (66.7%) | 0.541 |
| Mediastinal lymphadenopathy | 48 (64.0%) | 5 (55.6%) | 0.620 |
| Number of tissue samples acquired | 16.2±5.8 | 25.3±8.1 | <0.001 |
| Procedural time (minutes) | 58.5±12.5 | 67.6±15.4 | 0.050 |
| Intraprocedural talc pleurodesis | 70 (93.3%) | 3 (30.0%) | <0.001 |
| Final diagnosis with thoracoscopic biopsy | 0.031 | ||
| Lung cancer | 73 (97.3%) | 6 (60.0%) | |
| Mesothelioma | 2 (2.7%) | 2 (20.0%) | |
| Other malignancy* | 0 (0.0%) | 2 (20.0%) | |
| Thoracoscopic findings | |||
| Pleural nodule (<3 cm) | 67 (89.3%) | 6 (60.0%) | 0.012 |
| Pleural mass (>3 cm) | 16 (21.3%) | 2 (20.0%) | 0.923 |
| Pleural thickening | 60 (80.0%) | 10 (100%) | 0.119 |
| Plaque-like lesion | 46 (61.3%) | 5 (50.0%) | 0.492 |
| Diffuse infiltration | 44 (58.7%) | 3 (30.0%) | 0.087 |
| Adhesion grade, grade (0–1/2–3) | 44 (58.7%)/31 (41.3%) | 2 (20.0%)/8 (80.0%) | 0.021 |
*, one peritoneal origin cancer and one clear renal cell carcinoma. CXR, chest X-ray; Lt, left; Rt, right.
Association analysis for false negative frozen biopsy [permanent biopsy consistent with malignancy (n=85)]
| Clinical parameters | Univariate | Multivariate | |||
|---|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | ||
| Age | 1.024 (0.961–1.091) | 0.465 | 1.018 (0.941–1.102) | 0.650 | |
| Male sex | 1.714 (0.447–6.573) | 0.432 | 0.282 (0.041–1.952) | 0.200 | |
| Pleural nodule (<3 cm) | 0.179 (0.042–0.773) | 0.021 | 2.555 (0.406–16.103) | 0.318 | |
| Plaque like lesion | 0.630 (0.168–2.369) | 0.495 | – | – | |
| Adhesion grade (2–3 | 5.677 (1.128–28.580) | 0.035 | 13.187 (1.161–149.720) | 0.037 | |
| Diffuse infiltration | 0.302 (0.072–1.260) | 0.100 | – | – | |
| Effusion amount (>50% | 2.909 (0.342–24.749) | 0.328 | – | – | |
| Lung cancer | 0.041 (0.006–0.272) | 0.001 | 0.013 (0.001–0.181) | 0.001 | |
CI, confidence interval.
Patients with malignancy who were proven to have nonmalignant frozen section results
| Patient number | Age | Sex | Frozen section diagnosis | Final paraffin section diagnosis | Disagreement due to |
|---|---|---|---|---|---|
| 1 | 81 | F | Atypical mesothelial cells. No tissue invasion | Malignant mesothelioma, epithelioid type | Sampling error |
| 2 | 82 | F | Severe fibrosis, low cellularity | Metastatic adenocarcinoma from lung | Sampling error |
| 3 | 64 | F | Severe fibrosis | Primary peritoneal carcinoma | Sampling and interpretation error |
| 4 | 78 | F | Severe fibrosis, low cellularity | Metastatic adenocarcinoma from lung | Sampling error |
| 5 | 83 | M | Severe fibrosis, low cellularity | Metastatic adenocarcinoma from lung | Sampling error |
| 6 | 71 | M | Severe fibrosis, low cellularity | Metastatic clear cell renal cell carcinoma | Sampling error |
| 7 | 45 | F | Severe fibrosis, low cellularity | Metastatic adenocarcinoma from lung | Sampling error |
| 8 | 75 | M | Severe fibrosis, atypical mesothelial cell. Fat invasion | Malignant mesothelioma, epithelioid type | Interpretation error |
| 9 | 64 | M | Atypical cells in the background of inflammation | Metastatic combined small cell carcinoma with large cell neuroendocrine carcinoma | Interpretation error |
| 10 | 84 | F | Severe fibrosis, low cellularity | Metastatic adenocarcinoma from lung | Sampling error |